Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease
- 28 December 2011
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 32 (3) , 587-594
Abstract
This study aims to test the serum levels of interleukin-33 (IL-33) and soluble ST2 (sST2) in patients with chronic kidney disease (CKD) and to evaluate their association with disease severity.Keywords
This publication has 33 references indexed in Scilit:
- PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loopAmerican Journal of Physiology-Renal Physiology, 2010
- Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritisProceedings of the National Academy of Sciences, 2010
- CRP Polymorphisms and Progression of Chronic Kidney Disease in African AmericansClinical Journal of the American Society of Nephrology, 2010
- RETRACTED: The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences, 2009
- Aspects of Immune Dysfunction in End-stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- FGF-23–Klotho signaling stimulates proliferation and prevents vitamin D–induced apoptosisJournal of Cell Biology, 2008
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJournal of Clinical Investigation, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Biomarkers of inflammation and progression of chronickidney diseaseKidney International, 2005